Home>>Impaired fetal growth and arterial wall thickening: a randomized trial of ω-3 supplementation.

Search

About

Authors:
Address: Boden Institute of Obesity, Nutrition, Exercise and Eating Disorders, University of Sydney, Sydney, Australia. michael.skilton@sydney.edu.au
Journal:


Publication:


abstract

OBJECTIVES:

Impaired fetal growth is an independent cardiovascular risk factor and is associated with arterial wall thickening in children. No preventive strategy has been identified. We sought to determine whether dietary ω-3 fatty acid supplementation during early childhood prevents the association between impaired fetal growth and carotid arterial wall thickening.

METHODS:

The Childhood Asthma Prevention Study was a randomized, controlled single-blind trial in 616 children born at term, recruited antenatally from maternity hospitals in Sydney. Participants were randomized to either a 500-mg-daily fish oil supplement and canola-based margarines and cooking oil (ω-3 group), or a 500-mg-daily sunflower oil supplement and ω-6 fatty acid-rich margarines and cooking oil (control group), from the start of bottle-feeding or 6 months of age until 5 years of age. Carotid intima-media thickness (IMT), a noninvasive measure of subclinical atherosclerosis, was the primary endpoint of a cardiovascular substudy (CardioCAPS) at age 8 years. We examined the association of fetal growth with carotid IMT in children with birth weight <90th percentile (ω-3 group [n = 187], control group [n = 176]).

RESULTS:

In the control group, fetal growth was inversely associated with carotid IMT, but this was prevented in the ω-3 group (difference between groups of 0.041 mm [95% confidence interval 0.006, 0.075] per kg birth weight, adjusted for gestational age and gender, P(heterogeneity) = .02).

CONCLUSIONS:

The inverse association of fetal growth with arterial wall thickness in childhood can be prevented by dietary ω-3 fatty acid supplementation over the first 5 years of life.



Related Articles
Effect of omega-3 fatty acid concentrations in plasma on symptoms of asthma at 18 months of age.
Pediatr Allergy Immunol. 2004
Effect of omega-3 fatty acid concentrations in plasma on symptoms of asthma at 18 months of age.
Mihrshahi S, Peat JK, Webb K, Oddy W, Marks GB, Mellis CM, CAPS Team. Pediatr Allergy Immunol. 2004 Dec; 15(6):517-22.
Effect of dietary supplementation with omega-3 fatty acids on progression of atherosclerosis in carotid arteries.
Cardiovasc Res. 2002
Effect of dietary supplementation with omega-3 fatty acids on progression of atherosclerosis in carotid arteries.
Angerer P, Kothny W, Störk S, von Schacky C. Cardiovasc Res. 2002 Apr; 54(1):183-90.
Effect of n-3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial.
BMJ. 2012
Effect of n-3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial.
Palmer DJ, Sullivan T, Gold MS, Prescott SL, Heddle R, Gibson RA, Makrides M. BMJ. 2012 Jan 30; 344:e184. Epub 2012 Jan 30.
Review Omega-3 dietary supplements and the risk of cardiovascular events: a systematic review.
Clin Cardiol. 2009
Review Omega-3 dietary supplements and the risk of cardiovascular events: a systematic review.
Marik PE, Varon J. Clin Cardiol. 2009 Jul; 32(7):365-72.
Review Marine oil, and other prostaglandin precursor, supplementation for pregnancy uncomplicated by pre-eclampsia or intrauterine growth restriction.
Cochrane Database Syst Rev. 2006
Review Marine oil, and other prostaglandin precursor, supplementation for pregnancy uncomplicated by pre-eclampsia or intrauterine growth restriction.
Makrides M, Duley L, Olsen SF. Cochrane Database Syst Rev. 2006 Jul 19; (3):CD003402. Epub 2006 Jul 19.